Maciej Czerwinski

Dr. Maciej Czerwinski currently serves as a Director in the Scientific Consulting department at XenoTech. He received his Ph.D. from the University of Maryland at Baltimore Medical School in the Department of Pathology. Dr. Czerwinksi conducted his doctoral thesis research in the Laboratory of Dr. Frank Gonzalez at National Cancer Institute in Bethesda, followed by a post-doc at the Department of Pharmaceutics, University of Washington in Seattle. He has been with XenoTech since 1999 and guides the development of products and services for the in vitro analysis of drug safety. Dr. Czerwinski designed a patented method to analyze the in vitro cytokine-mediated drug-drug interactions between biologics and small molecule drugs. and he is also the inventor of XenoTech’s CryostaX single-freeze pooled hepatocytes.

Read Dr. Czerwinski’s recent interview with Outsourcing Pharma discussing DDI-related challenges in Drug Repurposing.